Dailiport 3 mg Retardkapseln
Country: Switzerland
Language: Italian
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Patient Information leaflet
(PIL)
07-06-2024
Summary of Product characteristics
(SPC)
07-06-2024
Active ingredient:
tacrolimus
Available from:
Sandoz Pharmaceuticals AG
ATC code:
L04AD02
INN (International Name):
tacrolimusum
Pharmaceutical form:
Retardkapseln
Composition:
tacrolimusum 3 mg ut tacrolimusum monohydricum, color.: E 110, E 129, E 133, excipiens pro capsula.
Class:
A
Therapeutic group:
Synthetika
Therapeutic area:
Immunsuppressivum
Authorization status:
zugelassen
Authorization date:
1970-01-01
Patient Information leaflet
•
Ricerca
•
Cerca SAI
•
Nuove omologazioni
•
Testi modificati
•
Scaricare
•
Aiuto
•
Accedi
IT
DE
FR
EN
AIPS - RICERCA INDIVIDUALE
Piattaforma di notifica elettronica per la vigilanza (ElViS)
Nessun risultato
Read the complete document
Summary of Product characteristics
•
Ricerca
•
Cerca SAI
•
Nuove omologazioni
•
Testi modificati
•
Scaricare
•
Aiuto
•
Accedi
IT
DE
FR
EN
AIPS - RICERCA INDIVIDUALE
Piattaforma di notifica elettronica per la vigilanza (ElViS)
Nessun risultato
Read the complete document
